Your browser is no longer supported. Please, upgrade your browser.
Settings
CNTG [NASD]
Centogene N.V.
Index- P/E- EPS (ttm)-1.25 Insider Own34.98% Shs Outstand18.05M Perf Week-1.75%
Market Cap206.58M Forward P/E- EPS next Y-1.60 Insider Trans0.00% Shs Float8.35M Perf Month-18.42%
Income-25.80M PEG- EPS next Q0.05 Inst Own49.20% Short Float1.98% Perf Quarter-20.07%
Sales154.90M P/S1.33 EPS this Y2.60% Inst Trans0.06% Short Ratio3.23 Perf Half Y-19.05%
Book/sh4.39 P/B2.17 EPS next Y-32.20% ROA-17.50% Target Price- Perf Year-46.46%
Cash/sh2.68 P/C3.56 EPS next 5Y- ROE-39.10% 52W Range8.61 - 27.10 Perf YTD-11.69%
Dividend- P/FCF- EPS past 5Y- ROI-22.30% 52W High-64.87% Beta-
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin36.40% 52W Low10.54% ATR0.64
Employees657 Current Ratio1.70 Sales Q/Q362.50% Oper. Margin-15.30% RSI (14)37.13 Volatility6.58% 5.92%
OptionableNo Debt/Eq0.37 EPS Q/Q173.60% Profit Margin-16.70% Rel Volume0.65 Prev Close9.24
ShortableYes LT Debt/Eq0.28 EarningsApr 15 BMO Payout- Avg Volume51.11K Price9.52
Recom1.20 SMA20-8.72% SMA50-17.16% SMA200-17.56% Volume33,410 Change3.03%
Apr-24-20Downgrade Evercore ISI Outperform → In-line $21
Dec-03-19Initiated Robert W. Baird Outperform
Dec-02-19Initiated Evercore ISI Outperform
Dec-02-19Initiated BTIG Research Buy
May-10-21 06:30AM  
May-07-21 06:32AM  
May-06-21 06:30AM  
May-05-21 06:30AM  
May-04-21 11:04AM  
May-03-21 11:50AM  
Apr-20-21 01:19AM  
Apr-19-21 03:12AM  
Apr-15-21 06:30AM  
Apr-14-21 06:30AM  
Apr-08-21 06:30AM  
Mar-09-21 06:30AM  
Feb-18-21 01:59AM  
Dec-18-20 10:02AM  
12:32AM  
Dec-16-20 07:03AM  
06:30AM  
Dec-09-20 06:30AM  
Dec-08-20 06:30AM  
Nov-25-20 06:30AM  
Nov-13-20 11:30AM  
Nov-09-20 04:00AM  
Nov-05-20 02:00AM  
Oct-20-20 08:17AM  
06:00AM  
05:30AM  
Oct-19-20 06:30AM  
Oct-14-20 08:14AM  
Sep-28-20 06:30AM  
Sep-25-20 06:32AM  
Sep-23-20 08:05AM  
07:50AM  
06:00AM  
03:30AM  
Sep-16-20 08:30AM  
Sep-10-20 08:15AM  
Sep-03-20 06:30AM  
Sep-01-20 08:30AM  
Aug-20-20 01:30AM  
Aug-19-20 02:00AM  
Aug-11-20 06:30AM  
Aug-04-20 06:30AM  
Jul-27-20 08:00AM  
Jul-23-20 02:30AM  
Jul-09-20 07:19PM  
06:30AM  
Jul-07-20 06:16PM  
Jul-06-20 06:30AM  
Jul-02-20 08:03AM  
Jul-01-20 10:22AM  
Jun-29-20 03:12PM  
02:30AM  
Jun-28-20 09:41PM  
Jun-23-20 06:30AM  
Jun-15-20 06:30AM  
06:00AM  
Jun-08-20 06:30AM  
Jun-04-20 11:00PM  
May-15-20 06:30AM  
May-12-20 01:16PM  
May-08-20 02:00PM  
May-06-20 06:30AM  
May-05-20 09:30AM  
Apr-23-20 06:30AM  
06:00AM  
Apr-21-20 11:00AM  
Apr-17-20 06:30AM  
Apr-16-20 11:24AM  
Apr-15-20 09:29AM  
Mar-18-20 02:13PM  
Mar-17-20 03:39PM  
Mar-09-20 10:05AM  
Feb-29-20 12:00AM  
Feb-25-20 06:30AM  
Feb-12-20 06:30AM  
Dec-16-19 06:37AM  
Dec-06-19 06:00AM  
Dec-05-19 06:28AM  
Dec-03-19 03:29PM  
Dec-02-19 03:00AM  
Nov-21-19 08:54AM  
Nov-18-19 08:00AM  
Nov-07-19 03:12AM  
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. The company develops rare disease platform, a data repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including RT-PCR and antigen testing services. It has a strategic collaboration with Shire International GmbH and Pfizer Inc.; a collaboration agreement with Dr. Bauer Laboratoriums GmbH, Rostock by providing the medical laboratory services to perform its COVID-19 testing business activities; and a license agreement with Fraport AG to operate a test center for COVID-19 testing/diagnostics at Frankfurt Airport, Germany. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.